Neil K Warma
CIK 1437911 · Chief Executive Officer · last filed 2026-05-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$64.0K
Companies
2
Total Filings
26
Lifetime Open-Market Net
$24.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMN | Chief Executive Officer | 6,183 | $10.35 | $64.0K | $0 | 5 | 2026-05-22 |
| Acer Therapeutics Inc. (OPXAW) Delisted | President, CEO and Acting CFO | 144,881 | — | — | $24.1K | 21 | 2016-05-18 |
Recent Filings · Page 2 of 3
26 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-11-12 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +28,571 | $0 | EDGAR |
| 2013-09-26 | Acer Therapeutics Inc. (OPXAW) Delisted | Conv (C) | +8,076 | $15.4K | EDGAR |
| 2013-07-02 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +581 | $895 | EDGAR |
| 2013-06-14 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-05-01 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +28,571 | $0 | EDGAR |
| 2013-01-31 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-01-28 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | +600 | $798 | EDGAR |
| 2012-07-27 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-10 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-01-06 | Acer Therapeutics Inc. (OPXAW) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.